Glasgow HIV Congress (2018)
The biennial Glasgow HIV Congress was held this year from 28 – 31 October and included numerous oral presentation with more than 300 studies also presented as posters.
Abstracts are available online as a supplement to the Journal of the IAS. The document is available as a PDF file or a continuous html page.
https://onlinelibrary.wiley.com/toc/17582652/2018/21/S8 (download page)
https://onlinelibrary.wiley.com/doi/full/10.1002/jia2.25187 (single page with all abstracts)
Webcasts from oral presentations will be available on the main conference website after the meeting (usually a week or two).
Reports will be added below as they become available.
- No additional neural tube defects with preconception dolutegravir: data from three birth outcome cohorts
- Viral dynamics of dolutegravir-based dual versus triple ART
- Dolutegravir non-inferior to low dose efavirenz in real-life African study conducted in Cameroon
- Ibalizumab: 48-week phase 3 results in 27 participants with MDR HIV